KAYAK THERAPEUTICS, INC.

Profile

Company Names

KAYAK THERAPEUTICS, INC.

Addresses

3317 BOWMAN AVENUE, AUSTIN, TX 78703

Phone Numbers

917.892.9996

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2025

State Incorporated:

DELAWARE

Total Amount Raised:

$18,570,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2026-05-12 
$11,940,000.00 
$25,000,000.00 
$13,060,000.00 
 
1
2025-09-11 
$6,630,000.00 
$10,000,000.00 
$3,370,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TYLER 
 
BROUS 
DIRECTOR
SHATTUCK LABS, INC.   |  CERSCI THERAPEUTICS INC.   |  COLDQUANTA, INC.   |  LCP QUANTUM PARTNERS III, LLC   |  RESET TECHNOLOGY CORP   |  LCP QUANTUM PARTNERS IV, LLC   |  BBK VENTURES FUND I, LP   |  LCP QUANTUM PARTNERS V, LLC   |  KAYAK THERAPEUTICS, INC.   |  LCP QUANTUM PARTNERS VI, LLC
JOSIAH 
 
HORNBLOWER 
EXECUTIVE OFFICER, DIRECTOR
BRIGHTLINE VENTURES III, LLC   |  BLUE PINE CRESCENT LIMITED PARTNERSHIP   |  BLUE PINE FINANCIAL OPPORTUNITIES FUND II, LP   |  PELICAN THERAPEUTICS, INC.   |  SHATTUCK LABS, INC.   |  BLUE PINE FINANCIAL OPPORTUNITIES FUND III, LP   |  KAYAK THERAPEUTICS, INC.
HORNBLOWER 
 
JOSIAH 
EXECUTIVE OFFICER, DIRECTOR
KAYAK THERAPEUTICS, INC.
CONOR 
 
RICHARDSON 
EXECUTIVE OFFICER
KAYAK THERAPEUTICS, INC.
TAYLOR 
 
SCHREIBER 
DIRECTOR
PELICAN THERAPEUTICS, INC.   |  SHATTUCK LABS, INC.   |  KAYAK THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2026-05-12 
2025-09-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#